Condition: End Stage Renal Disease (ESRD) · Sponsor: Chengdu Qingshan Likang Pharmaceutical Co., Ltd
This is a multicenter, randomized, parallel controlled Phase IV clinical study to evaluate the safety and efficacy of amino acid (15) peritoneal dialysis solution in patients undergoing peritoneal dialysis with malnutrition in CAPD patients undergoing peritoneal dialysis maintenance.
This description comes directly from the study's public registry record.
Qian Deng · 86 136 9940 1416 · dq0416@qq.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Recruiting |
| Peking University People&'s Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Wuhan NO.1 Hospital | Wuhan, Hubei, China | Recruiting |
| The Third Xiangya Hospital of Central South University | Changsha, Hunan, China | Recruiting |
| West China Hospital, Sichuan University | Chengdu, Sichuan, China | Recruiting |
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, China | Recruiting |
| Ganzhou People's Hospital | Ganzhou, China | Recruiting |
| Affiliated Hospital of Guangdong Medical University | Guangdong, China | Recruiting |
| The First Affiliated Hospital, Sun Yat-sen University | Guangzhou, China | Recruiting |
| The Affiliated Hospital of Southwest Medical University | Luzhou, China | Recruiting |
| Meishan Hospital, West China Hospital, Sichuan University (Meishan People's Hospital) | Meishan, China | Recruiting |
| Jiangsu Province Hosipital | Nanjing, China | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06597201